Identification of a cannabinoid analog as a new type of designer drug in a herbal product

153Citations
Citations of this article
64Readers
Mendeley users who have this article in their library.

Abstract

A new type of designer drug, a cannabinoid analog (1), was found in a herbal product distributed on the illegal drug market in Japan in expectation of its narcotic effect. The structure of 1 was identified by LC-MS, GC-MS, high-resolution MS, and NMR analyses. Compound 1 showed a molecular weight of 332, and accurate mass measurement exhibited its elemental composition to be C22H36O2. Together, the mass and NMR spectromet-ric data revealed that 1 was (1RS,3SR)-3-[4-(1,1-dimethyloctyl)-2- hydroxyphenyl]cyclohexan-1-ol, which was first synthesized in 1979 by a group at Pfizer Inc. and reported as a potent cannabi-noid analog possessing cannabinoid receptor binding activity and analgesic activity in the 1990s. This is the first report to identify a cannabinoid analog in an illegal drug. © 2009 Pharmaceutical Society of Japan.

Cite

CITATION STYLE

APA

Uchiyama, N., Kikura-Hanajiri, R., Kawahara, N., Haishima, Y., & Goda, Y. (2009). Identification of a cannabinoid analog as a new type of designer drug in a herbal product. Chemical and Pharmaceutical Bulletin, 57(4), 439–441. https://doi.org/10.1248/cpb.57.439

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free